Latest price-to-book ratio
4D Molecular Therapeutics Price-to-book ratio
Direct answer
4D Molecular Therapeutics's price-to-book ratio is 1.46x.
The verified market snapshot reports 1.46x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 25, 2026.
Get free 4D Molecular Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 1.46x
Explore related company data
View 4D Molecular Therapeutics's market capitalizationView 4D Molecular Therapeutics's return on equityView 4D Molecular Therapeutics's dividend yieldView 4D Molecular Therapeutics's 52-week price rangeView 4D Molecular Therapeutics's revenue growthView 4D Molecular Therapeutics's profit marginView 4D Molecular Therapeutics's debt-to-equity ratioView all 4D Molecular Therapeutics key metricsReturn to 4D Molecular Therapeutics profile